seed
Stage
About
ProNovo Therapeutics develops novel precision medicines targeting neuropsychiatric disorders, including major depressive disorder and schizophrenia, through a mechanism-based, precision medicine approach leveraging genetic susceptibility and biomarker integration.
Explore ProNovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.